Publicaciones científicas

The impact of deep brain stimulation on executive function in Parkinson's disease

M. Jahanshahi (1,2), C. M. A. Ardouin (3), R. G. Brown (2), J. C. Rothwell (2), J. Obeso (5), A. Albanese (6), M. C. Rodríguez-Oroz (5), E. Moro (4), A. L. Benabid (3), P. Pollak (3) and P. Limousin-Dowsey (2)
(1) Department of Clinical Neurology, Institute of Neurology
(2) MRC Human Movement and Balance Unit, The National Hospital for Neurology and Neurosurgery, London
(3) Neuroscience Department, Grenoble France,
(4) Functional Neurology and Neurosurgery Center, Clínica Quirón, San Sebastián
(5) Department of Neurology and Neurosurgery, Division of Neuroscience, Clínica Universitaria and Medical School, University of Navarra, Pamplona, Spain
(6) Universita Cattolica, Instituto di Neurologia, Rome, Italy

Revista: Brain

Fecha: 01-jun-2000

Neurología

Deep brain stimulation (DBS) of the subthalamic nucleus (STN) or the internal segment of the globus pallidus (GPi) improves Parkinson's disease and increases frontal blood flow.

We assessed the effects of bilateral DBS on executive function in Parkinson's disease patients, seven with electrodes implanted in the STN and six in the GPi. Patients were assessed off medication with stimulators off, on and off again. The groups showed differential change with stimulation on the Reitan Trail-Making test (TMT B) (STN more improved) and on some measures of random number generation and Wisconsin Card Sorting (STN improved, GPi worse with stimulation).

Across the groups, stimulation speeded up responding (Stroop control trial, TMT A) and improved performance on paced serial addition and missing digit tests. Conversely, conditional associative learning became more errorful with stimulation across the two groups. In general, change in performance with stimulation was significant for the STN but not the GPi group. These results support two opposite predictions. In support of current models of Parkinson's disease, 'releasing the brake' on frontal function with DBS improved aspects of executive function.

Conversely, disruption of basal ganglia outflow during DBS impaired performance on tests requiring changing behaviour in novel contexts as predicted by Marsden and Obeso in 1994.

CITA DEL ARTÍCULO  Brain. 2000 Jun;123 ( Pt 6):1142-54

tal vezLE INTERESE

¿QUÉ TECNOLOGÍA UTILIZAMOS?

La Clínica es el hospital privado con mayor dotación tecnológica de España, todo en un único centro.

Imagen de un PET, tecnología de vanguardia en la Clínica Universidad de Navarra

NUESTROS
PROFESIONALES

Los profesionales de la Clínica realizan una labor continuada de investigación y formación, siempre en beneficio del paciente.

Imagen profesionales de la Clínica Universidad de Navarra

POR QUÉ VENIR
A LA CLÍNICA

Conozca por qué somos diferentes a otros centros sanitarios. Calidad, rapidez, comodidad y resultados.

Imagen del edificio de la Clínica Universidad de Navarra